Suzanne M. Boyle

Suzanne M. Boyle

Auto-generated profile, based on publicly available information

Suzanne M. Boyle

Division of Nephrology, Hypertension, and Kidney Transplantation, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in American Journal of Kidney Diseases
Verified
Journal Article
Closed access
PDF file
SBSuzanne M. Boyle
Suzanne M. Boyle
RWRhonda Washington
Rhonda Washington
PMPatricia McCann
Patricia McCann
SKSheetal Koul
Sheetal Koul
BMBrett McLarney
Brett McLarney
CGCrystal A. Gadegbeku
Crystal A. Gadegbeku

1 September 2017 in Transplantation Proceedings
Verified
Journal Article
Closed access
SBS.M. Boyle
S.M. Boyle
NAN. Ali
N. Ali
AOAnthony J Olszanski
Anthony J Olszanski
DPD.J. Park
D.J. Park
GXG. Xiao
G. Xiao
ADA.M. Doyle
A.M. Doyle

16 September 2017 in Transplant Infectious Disease
Verified
Journal Article
Closed access
PDF file
DLDong Heun Lee
Dong Heun Lee
SBSuzanne M. Boyle
Suzanne M. Boyle
GMGregory E. Malat
Gregory E. Malat
CKChristopher Kern
Christopher Kern
CMCharles Milrod
Charles Milrod
ADAlden Doyle
Alden Doyle

29 January 2020 in Transplant Infectious Disease
Verified
Journal Article
Closed access
PDF file
SBSuzanne M. Boyle
Suzanne M. Boyle
KFKallie Fehr
Kallie Fehr
CDCatylin Deering
Catylin Deering
ARAbbas Raza
Abbas Raza
MHMeera N. Harhay
Meera N. Harhay
DLDong Heun Lee
Dong Heun Lee

14 July 2015 in Seminars in Dialysis
Verified
Journal Article
Closed access
PDF file
SBSuzanne M. Boyle
Suzanne M. Boyle
BJBenjamin Jacobs
Benjamin Jacobs
FSFarzana A. Sayani
Farzana A. Sayani
BHBrenda Hoffman
Brenda Hoffman

3 May 2021 in Journal of the American Society of Nephrology
Verified
Journal Article
Closed access
PDF file
KPKurtis A. Pivert
Kurtis A. Pivert
SBSuzanne M. Boyle
Suzanne M. Boyle
SHSusan M. Halbach
Susan M. Halbach
LCLili Chan
Lili Chan
HSHitesh H. Shah
Hitesh H. Shah
SSStephen M. Sozio
Stephen M. Sozio
Aims: Mutation of the KRAS gene predicts the clinical response to the monoclonal antibody cetuximab in patients with advanced colorectal cancer (CRC). This study aimed to perform KRAS mutation detection on formalin-fixed paraffin-embedded (FFPE) tumour tissue by two different methods for comparison. Methods: The FFPE sample was microdissected to enrich for tumour cells. KRAS exon 2 mutations were performed on 100 Chinese patients with CRC by direct nucleotide sequencing and high-resolution melting (HRM) analysis. Results: KRAS exon 2 mutations were detected in a total of 62 patients with the two methods combined, comprising 11 different mutant alleles. Three common mutations p.Gly12Asp, p.Gly12Val and p.Gly13Asp accounted for approximately 70% of all cases. The concordant rate between the two methods was 95%. Four mutations not initially detected by direct sequencing were identified by HRM and confirmed by sequencing of the HRM amplicons. One mutation detected by direct sequencing was inadvertently grouped as a wild-type allele by HRM software, but this was readily rectified through manual review. Conclusion: HRM analysis is a sensitive method of detecting KRAS mutation on FFPE tumour tissue to guide cetuximab treatment and is applicable to routine molecular diagnostic service. Utilisation of HRM to screen for mutations upfront economises the resource used in the sequencing reaction.